Sedation study for heart bypass patients in ICU
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two types of sedation for older adults recovering from heart bypass surgery in the ICU. It aims to see which drug keeps your heart function more stable while you are on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older
- You have had coronary artery bypass surgery
- You will need a breathing tube for more than 8 hours after surgery
- You are in the cardiac surgery ICU at Zhongshan Hospital
- You do not have a pacemaker or severe heart block (over degree II A-V block)
- You are not allergic to propofol or remimazolam
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of managing blood pressure during heart bypass surgery without a heart-lung machine. The goal is to see if a more targeted approach can improve recovery and reduce complications.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study tests whether a sedative called remimazolam can help protect the heart during surgery in older adults. If you are 65 or older and having a longer surgery with general anesthesia, this trial may be for you.
This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.
This trial tests whether a newer sedative (remimazolam) or a commonly used one (dexmedetomidine) is better at preventing delirium after planned heart surgery that requires a heart-lung machine. If you are having elective coronary bypass or valve surgery, you may be able to join.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.